RTI Surgical® Announces Appointment of Jeffrey C. Lightcap to Board of Directors
March 08 2019 - 04:07PM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, today announced the appointment of Jeffrey
C. Lightcap to its Board of Directors, effective
immediately.
Mr. Lightcap has significant experience in
helping drive growth in medical technology companies. He is
currently a Senior Managing Director
at HealthCor Partners Management, L.P., a growth equity
investor focused on late stage venture and early
commercial stage healthcare companies in the diagnostic,
therapeutic and med tech sectors. Prior
to HealthCor, Mr. Lightcap served as a Senior
Managing Director at JLL Partners, a leading middle-market private
equity firm. Prior to JLL Partners, Mr. Lightcap served
as a Managing Director at Merrill Lynch & Co.,
Inc. Mr. Lightcap currently serves as Chairman of
the Board of Directors of Corindus Vascular Robotics,
Inc. and serves on the Board of Directors
of Heartflow, Inc. and several smaller private companies.
He also was a Member of the Board of Managers at Paradigm Spine,
LLC.
“Jeff has extensive experience navigating the reimbursement
landscape and advancing access to medical devices with substantial
clinical data and high-growth potential,” said Camille Farhat,
President and CEO, RTI Surgical. “We are enthusiastic about his
addition to our Board and believe he will make an important
contribution as we progress on our ongoing strategic transformation
to reduce complexity, drive operational excellence and accelerate
growth.”
About RTI Surgical Holdings, Inc. RTI
Surgical Holdings, Inc. is a leading global surgical implant
company providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in spine, sports medicine, plastic surgery, orthopedic and
trauma procedures and are distributed in more than 40 countries.
RTI has four manufacturing facilities throughout the U.S. and
Europe. RTI is accredited in the U.S. by the American Association
of Tissue Banks and is a member of AdvaMed. For
more information, please visit www.rtix.com. Connect with us
on LinkedIn and Twitter.
Forward-Looking
Statements This communication
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on management’s current
expectations, estimates and projections about our industry, our
management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. In addition, except for historical
information, any statements made in this communication about
anticipated financial results, growth rates, new product
introductions, future operational improvements, gaining market
share and results or regulatory actions or approvals or changes to
agreements with distributors also are forward-looking statements.
These statements are not guarantees of future performance
and are subject to risks and uncertainties, including the risks
described in public filings with the U.S. Securities and Exchange
Commission (SEC). Our actual results may differ materially from the
anticipated results reflected in these forward-looking statements.
Copies of the company's SEC filings may be obtained by contacting
the company or the SEC or by visiting RTI's website
at www.rtix.com or the SEC's website
at www.sec.gov.
MEDIA AND INVESTOR CONTACT: Molly
Poarch mpoarch@rtix.com +1 224 287 2661
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Feb 2024 to Mar 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Mar 2023 to Mar 2024